Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Efficacy evaluation under type II censored plan with postclassified samples.

Siu-Keung Tse1, Chunyan Yang, Hak-Keung Yuen

  • 1Department of Management Sciences, City University of Hong Kong, Kowloon Tong, Kowloon, Hong Kong. mssktse@cityu.edu.hk

Journal of Biopharmaceutical Statistics
|October 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative repair efficacy of three mesenchymal stem cell sources in rat full-thickness talar cartilage defects.

Scientific reports·2026
Same author

Non-antibiotic drug-induced microbiotoxicity as a pharmacological variable.

Chemico-biological interactions·2026
Same author

Corrigendum to "Single-cell RNA sequencing reveals depot-specific characteristics of adipose progenitor cells in ducks" [Poultry Science, Volume 105/Issue 7, July 2026, 107004].

Poultry science·2026
Same author

Fear of progression and associated factors in glaucoma patients: a latent profile analysis.

BMC psychology·2026
Same author

Liver cancer derived high core fucosylation sEV elict malignancy by activating PI3K/AKT signaling pathway.

Cell communication and signaling : CCS·2026
Same author

Causal link between maternal PCOS and fetal/neonatal hemorrhagic and hematological disorders: A 2-sample MR study.

Medicine·2026

This study evaluates intervention efficacy using Type II censoring with postclassified groups. Findings suggest fixed sample size results may apply, aiding clinical trial data analysis.

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Survival Analysis

Background:

  • Clinical trial data often requires postclassification into subgroups for efficacy assessment.
  • The number of observations in these subgroups represents random outcomes.
  • Efficacy evaluation under Type II censoring with random subgroup sizes is complex.

Purpose of the Study:

  • To discuss parameter estimation and hypothesis testing for postclassified data under Type II censoring.
  • To assess the applicability of fixed sample size methods to postclassified scenarios.
  • To provide guidance for practitioners analyzing such data.

Main Methods:

  • Utilizing Type II censoring for survival data analysis.
  • Employing statistical methods for parameter estimation in random subgroups.

Related Experiment Videos

  • Conducting a numerical study to compare fixed vs. random sample size outcomes.

    • Main Results:

    • The study investigates the validity of using fixed sample size results for postclassified data.
    • Numerical simulations explore the behavior of estimators and tests under these conditions.
    • Results offer insights into the robustness of standard methods.

    Conclusions:

    • The findings provide practical guidance for analyzing clinical trial data with postclassified groups.
    • Understanding the impact of random subgroup sizes is crucial for accurate efficacy evaluation.
    • This research contributes to the statistical methodology for complex clinical trial designs.